Literature DB >> 24365014

Hydroxycholoroquine-induced hyperpigmentation.

Adnan Mir1, Kevin P Boyd, Shane A Meehan, Beth McLellan.   

Abstract

A 57-year-old woman with systemic lupus erythematosus and Sjögren syndrome presented with blue-grey hyperpigmentation of the face, upper back, and dorsal aspects of the feet after seven years of therapy with hydroxychloroquine. We present an unusual case of drug-induced hyperpigmentation.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 24365014

Source DB:  PubMed          Journal:  Dermatol Online J        ISSN: 1087-2108


  3 in total

1.  Hyperpigmentation Induced by Combination Therapy With Telmisartan-Hydrochlorothiazide.

Authors:  Rosa Giménez-García
Journal:  J Clin Hypertens (Greenwich)       Date:  2015-09-11       Impact factor: 3.738

2.  Frontal fibrosing alopecia and extrafacial lichen planus pigmentosum in a caucasian woman.

Authors:  Monserrat Franco-Muñoz; Monica García-Arpa; Belén Lozano-Masdemont; Claudia Ramos-Rodríguez
Journal:  An Bras Dermatol       Date:  2017       Impact factor: 1.896

3.  Safety of hydroxychloroquine in COVID-19 and other diseases: a systematic review and meta-analysis of 53 randomized trials.

Authors:  Can Chen; Kunming Pan; Bingjie Wu; Xiaoye Li; Zhangzhang Chen; Qing Xu; Xiaoyu Li; Qianzhou Lv
Journal:  Eur J Clin Pharmacol       Date:  2020-08-11       Impact factor: 2.953

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.